Cognitive Deficit in Schizophrenia

1

Review clinical trials related to Cognitive Deficit in Schizophrenia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Efficacy and Mechanisms of TUS on Cognitive Deficits in Schizophrenia: Based on the Hippocampal-Prefrontal Circuit

Cognitive deficit is a core symptom of schizophrenia related to poorer functional outcome. Prior studies indicated that abnormalities in the hippocampus-prefrontal circuit and glutamate/GABA imbalances may lead to cognitive deficits. Based on the current background and our previous studies, it has been proved that TUS can modulate neural excitability and plasticity in the hippocampus. In this double-blind, randomized study, the efficacy of different treatment options and mechanisms of TUS on cognitive deficits will be investigated.

Participants needed: 140
Trial details
Age: 18-50Biological sex: AllType: InterventionalSponsor: Shanghai Mental Health CenterUpdated: Jun 12, 2026Locations: 1
Eligibility criteria

Meet the DSM-5 diagnostic criteria for schizophrenia ; [+4]

Current or past neurological illness, severe physical diseases, substance abuse... [+5]